High NT-proBNP Levels Linked to Longer Hospital Stay and Higher Mortality in HF Patients: Study

India: A new retrospective study from Father Muller Medical College, Mangalore, has highlighted the critical role of NT-proBNP levels in predicting hospital outcomes among patients admitted with heart failure. Published…

Continue ReadingHigh NT-proBNP Levels Linked to Longer Hospital Stay and Higher Mortality in HF Patients: Study

Alkem Gets CDSCO Panel Nod to Market Synthetic Semaglutide Injection in Multiple Strengths for Type 2 Diabetes

New Delhi: Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organization (CDSCO) for the manufacture and marketing of Semaglutide…

Continue ReadingAlkem Gets CDSCO Panel Nod to Market Synthetic Semaglutide Injection in Multiple Strengths for Type 2 Diabetes

Final Call for Unplaced B.Pharm 2025 Candidates: Kerala CEE Opens Special Allotment Window

Thiruvananthapuram: In a move that opens a final admission window for pharmacy aspirants, the Commissioner for Entrance Examinations (CEE) Kerala has launched a special allotment for B.Pharm 2025, exclusively for…

Continue ReadingFinal Call for Unplaced B.Pharm 2025 Candidates: Kerala CEE Opens Special Allotment Window

Proton Pump Inhibitors Linked to Worse Survival in Newly Diagnosed Glioblastoma: Study

A new study published in the Journal of American Medical Association showed that in patients with newly diagnosed glioblastoma, proton pump inhibitors (including ALDH1A1-activating PA-PPIs), which are frequently used to…

Continue ReadingProton Pump Inhibitors Linked to Worse Survival in Newly Diagnosed Glioblastoma: Study